Lilly
Credit: Michael Vi/Shutterstock.com

Rankings 2022

  • INNOVATION – Commended
  • RESEARCH AND DEVELOPMENT – Commended

Clinical Trials Excellence Rankings 2022 – The Verdict

Lilly is an American pharmaceutical company that is ranked for Innovation and R&D in the 2022 Clinical Trials Arena Excellence Rankings.

In terms of Covid-related R&D, this research period has seen Eli Lilly focus on developing its bamlanivimab antibody drug. The recombinant drug has been especially effective in lowering the risk of contracting symptomatic Covid-19 in nursing homes. The drug was also proven to be effective co-administered with VIR-7831 in a trial collaboration between Lilly, Vir and GSK.

The company has also been active in the field of age-related diseases, specifically it has been trialling its donanemab drug for the treatment of Alzheimer’s disease. 

The company has also been active in the field of age-related diseases, specifically it has been trialling its donanemab drug for the treatment of Alzheimer’s disease

Another area where Eli Lilly has been especially active has been oncology, with positive results from its Retevmo (selpercatinib) treatment for hyroid cancers and gastrointestinal malignancies. In collaboration with Innovent the company has also been developing treatments for hepatocellular carcinoma.

Cardiovascular trials have also been a strong point and the company’s empagliflozin drug, developed in conjunction with Boehringer, has met its primary goal in a heart failure trial. The safety and efficacy of Jardiance (empagliflozin) has also been proved in a Phase III trial. 

The company has also been focusing on treatments for immune system diseases, such as ulcerative colitis, rheumatoid arthritis and alopecia areata and conducted R&D in the fields of diabetes, dermatology and urological diseases.

Bamlanivimab (LY-CoV555)
Bamlanivimab is a neutralising monoclonal antibody. Credit: Eli Lilly and Company.

Profile

Eli Lilly and Co (Lilly) is a healthcare company that is engaged in the discovery, development, and marketing of human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men’s health and musculoskeletal problems. 

The company distributes its pharmaceutical health products through independent wholesale distributors. Lilly conducts research and development activities to discover and deliver innovative medicines. 

It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company also offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.